Alendronate: which country? [Design Issues]

posted by jchapdelaine – 2010-05-13 00:16 (5886 d 15:36 ago) – Posting: # 5336
Views: 4,097

Regarding the use of plasma or urine, originally it was not possible to analyze the plasma levels due to sensivitiy issues for bisphosphonates. However labs now have the sensitivity to analyze plasma PK profiles. Last year I discussed with FDA why for alendronate it is recommended to analyze in urine when plasma is available. The response was that it is an old recommendation, and that if plasma PK analysis is possible, then this should be used.
My lab currently has a method for both plasma and urine analysis, however as of now, sponsors have only used the urine method.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
116 visitors (0 registered, 116 guests [including 13 identified bots]).
Forum time: 15:53 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5